메뉴 건너뛰기




Volumn 42, Issue 3, 2010, Pages 938-939

The survival of heart transplant recipients using cyclosporine and everolimus is not inferior to that using cyclosporine and mycophenolate

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DRUG DERIVATIVE; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

EID: 77955493955     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.002     Document Type: Conference Paper
Times cited : (8)

References (9)
  • 1
    • 70349186925 scopus 로고    scopus 로고
    • Management of allosensitized cardiac transplant candidates
    • M. Velez, and M.R. Hohnson Management of allosensitized cardiac transplant candidates Transplant Rev 23 2009 235
    • (2009) Transplant Rev , vol.23 , pp. 235
    • Velez, M.1    Hohnson, M.R.2
  • 2
  • 3
    • 33645751447 scopus 로고    scopus 로고
    • New drug application, certican (everolimus) for the proposed indication of prophylaxis of rejection in heart transplantation
    • W.R. Hiatt, and S.E. Nissen New drug application, certican (everolimus) for the proposed indication of prophylaxis of rejection in heart transplantation Circulation 113 2006 e394
    • (2006) Circulation , vol.113 , pp. 394
    • Hiatt, W.R.1    Nissen, S.E.2
  • 4
    • 19244366021 scopus 로고    scopus 로고
    • Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients
    • H.J. Eisen, E.M. Tuzcu, and R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients N Engl J Med 349 2003 847
    • (2003) N Engl J Med , vol.349 , pp. 847
    • Eisen, H.J.1    Tuzcu, E.M.2    Dorent, R.3
  • 5
    • 0034466751 scopus 로고    scopus 로고
    • What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
    • J. Kobashigawa What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? Curr Control Trials Cardiovasc Med 1 2000 166
    • (2000) Curr Control Trials Cardiovasc Med , vol.1 , pp. 166
    • Kobashigawa, J.1
  • 6
    • 10844292763 scopus 로고    scopus 로고
    • Immunosuppressive drugs for kidney transplantation
    • P.F. Halloran Immunosuppressive drugs for kidney transplantation N Engl J Med 351 2004 2715
    • (2004) N Engl J Med , vol.351 , pp. 2715
    • Halloran, P.F.1
  • 7
    • 53149101690 scopus 로고    scopus 로고
    • Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus
    • S.S. Wang, N.K. Chou, and N.H. Chi Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus Transplant Proc 40 2008 2607
    • (2008) Transplant Proc , vol.40 , pp. 2607
    • Wang, S.S.1    Chou, N.K.2    Chi, N.H.3
  • 8
    • 33845431637 scopus 로고    scopus 로고
    • Effect of plasmapheresis for acute humoral rejection after heart transplantation
    • S.S. Wang, N.K. Chou, and W.J. Ko Effect of plasmapheresis for acute humoral rejection after heart transplantation Transplant Proc 38 2006 3692
    • (2006) Transplant Proc , vol.38 , pp. 3692
    • Wang, S.S.1    Chou, N.K.2    Ko, W.J.3
  • 9
    • 33846045141 scopus 로고    scopus 로고
    • Influence of everolimus on neoral pharmacokinetics in Chinese de novo cardiac transplant recipients
    • C.H. Wang, N.K. Chou, and F.L.L. Wu Influence of everolimus on neoral pharmacokinetics in Chinese de novo cardiac transplant recipients Transplant Proc 38 2006 2032
    • (2006) Transplant Proc , vol.38 , pp. 2032
    • Wang, C.H.1    Chou, N.K.2    Wu, F.L.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.